MEDIENCE CO., LTD. – Trademark Portfolio
Entity Type: 03
MEDIENCE CO., LTD. owns a portfolio of 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as B&B, DR.ATO, MEDIENCE, DR. ATOMILD, and DR. ATOPEACE. Of these, 12 are registered and 1 is pending. The portfolio spans 5 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 5 (Pharmaceuticals). Headquartered in SEOUL.
4, NONHYEON-RO 64-GIL, GANGNAM-GU,
SEOUL 06231 , KR
Showing of trademarks Trademarks
Trademark Classifications
MEDIENCE CO., LTD.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does MEDIENCE CO., LTD. have?
MEDIENCE CO., LTD. has 13 U.S. trademarks filed with the USPTO. Of these, 12 registered, 1 pending.
What trademark classes does MEDIENCE CO., LTD. file in?
MEDIENCE CO., LTD. files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 21 (Housewares). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are MEDIENCE CO., LTD.'s most well-known trademarks?
MEDIENCE CO., LTD.'s registered trademark portfolio includes well-known marks such as B&B, DR.ATO, MEDIENCE, DR. ATOMILD, and DR. ATOPEACE. These are among 12 currently registered trademarks in the portfolio.
What is MEDIENCE CO., LTD.'s trademark registration success rate?
MEDIENCE CO., LTD. has a 100% trademark registration rate, with 12 out of 12 resolved applications resulting in successful registration. Currently, 1 application is pending review.